Summit Therapeutics Cash from Investing (TTM) Trends

Summit Therapeutics Inc (SMMT)

8.39 +0.30 (+3.71%) USD | NASDAQ | Jun 14, 16:00

8.38 -0.01 (-0.12%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	77.16M
December 31, 2023	-587.77M
September 30, 2023	-648.33M
June 30, 2023	-644.83M
March 31, 2023	-645.33M
December 31, 2022	-0.624M
September 30, 2022	-0.754M
June 30, 2022	-0.77M
March 31, 2022	-0.628M
December 31, 2021	-0.306M
September 30, 2021	-0.236M
June 30, 2021	-0.284M
March 31, 2021	-0.266M
December 31, 2020	-0.421M
September 30, 2020	-0.4038M
June 30, 2020	-0.6198M
March 31, 2020	-0.4894M
October 31, 2019	-0.5527M
July 31, 2019	-0.5241M

Date	Value
April 30, 2019	-0.2937M
January 31, 2019	-0.331M
October 31, 2018	-6.970M
July 31, 2018	-7.023M
April 30, 2018	-7.099M
January 31, 2018	-7.420M
October 31, 2017	-0.5792M
July 31, 2017	-0.5362M
April 30, 2017	-0.4549M
January 31, 2017	-0.10M
October 31, 2016	-0.0412M
July 31, 2016	-0.0692M
April 30, 2016	-0.0417M
January 31, 2016	-0.0513M
October 31, 2015	-0.0587M
July 31, 2015	-0.0036M
April 30, 2015	0.0205M
January 31, 2015	0.0241M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-648.33M

Minimum

Sep 2023

77.16M

Maximum

Mar 2024

-129.26M

Average

-0.5527M

Median

Oct 2019

Cash from Investing (TTM) Benchmarks